4.7 Article

Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively

期刊

DIABETOLOGIA
卷 59, 期 6, 页码 1214-1221

出版社

SPRINGER
DOI: 10.1007/s00125-016-3908-5

关键词

Association analysis; BMI; CDKAL1; FTO; Genetics; Non-additive effects; Type 2 diabetes; UK Biobank

资金

  1. European Research Council [323195: SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC]
  2. Wellcome Trust [104150/Z/14/Z]
  3. Royal Society [104150/Z/14/Z]
  4. European Regional Development Fund
  5. Diabetes Research and Wellness Foundation fellowship
  6. Medical Research Council [MR/M005070/1]
  7. Wellcome Trust Institutional Strategic Support Award [WT097835MF]
  8. European Research Council award [323195]
  9. European Research Council (ERC) [323195] Funding Source: European Research Council (ERC)
  10. Medical Research Council [G0500070, G0601261] Funding Source: researchfish
  11. MRC [G0601261, G0500070] Funding Source: UKRI
  12. Wellcome Trust [104150/Z/14/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Aims/hypothesis Genome-wide association (GWA) studies have identified hundreds of common genetic variants associated with obesity and type 2 diabetes. These studies have usually focused on additive association tests. Identifying deviations from additivity may provide new biological insights and explain some of the missing heritability for these diseases. Methods We performed a GWA study using a dominance deviation model for BMI, obesity (29,925 cases) and type 2 diabetes (4,040 cases) in 120,286 individuals of British ancestry from the UK Biobank study. We also investigated whether single nucleotide polymorphisms previously shown to be associated with these traits showed any enrichment for departures from additivity. Results Known obesity-associated variants in FTO showed strong evidence of deviation from additivity (p(DOMDEV) = 3 x 10(-5)) through a recessive effect of the allele associated with higher BMI. The average BMI of individuals carrying zero, one or two BMI-raising alleles was 27.27 (95% CI 27.22, 27.31) kg/m(2), 27.54 (95% CI 27.50, 27.58) kg/m(2) and 28.07 (95% CI 28.00, 28.14) kg/m(2), respectively. A similar effect was observed in 105,643 individuals from the GIANT Consortium (p(DOMDEV) = 0.003; meta-analysis p(DOMDEV) = 1 x 10(-7)). For type 2 diabetes, we detected a recessive effect (p(DOMDEV) = 5 x 10(-4)) at CDKAL1. Relative to homozygous non-risk allele carriers, homozygous risk allele carriers had an OR of 1.48 (95% CI 1.32, 1.65), while the heterozygous group had an OR of 1.06 (95% CI 0.99, 1.14), a result consistent with that of a previous study. We did not identify any novel associations at genome-wide significance. Conclusions/interpretation Although we found no evidence of widespread non-additive genetic effects contributing to obesity and type 2 diabetes risk, we did find robust examples of recessive effects at the FTO and CDKAL1 loci. Access to research materials Summary statistics are available at www.t2diabetesgenes.org and by request (a.r.wood@exeter.ac.uk). All underlying data are available on application from the UK Biobank.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据